Completed OBSERVATIONAL NCT00181831

Spectroscopy in Children and Adolescents With Bipolar Disorder

Proton Magnetic Resonance Spectroscopy in Children and Adolescents With Bipolar Disorder

Sponsor: Janssen Pharmaceutica

Interventions Proton Magnetic Resonance Spectroscopy

Updated 7 times since 2017 Last updated: Jun 12, 2013 Started: Dec 31, 2002 Primary completion: Nov 30, 2005 Completion: Nov 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on ADHD and Bipolar Disorder, this trial is completed. The trial is conducted by Janssen Pharmaceutica and has accumulated 7 data snapshots since 2002. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Janssen Pharmaceutica
Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States